INTRODUCTION: Schizophrenia is associated with a high prevalence of cigarette smoking. The aims of this study were to compare smokers with schizophrenia (SS) and control smokers without psychiatric illness (CS) on (a) cigarette craving and nicotine withdrawal symptom severity during a 72-hr smoking abstinence period; (b) nicotine reinforcement, before and after abstinence; and (c) latency to smoking lapse following abstinence. We also explored mediators of smoking lapse in SS and CS. METHODS: SS (n = 28) and CS (n = 27) underwent a nicotine versus denicotinized cigarette puff choice task before and after a 72-hr period of smoking abstinence that was experimentally controlled by providing cash reinforcement contingent on biochemical verification of abstinence. Twenty-four hours after the second choice task, participants could receive a low-value reinforcer if they had continued to abstain since the previous day. Those who remained abstinent were recontacted a week later to determine time of their smoking lapse. RESULTS: SS reported more severe cigarette craving and nicotine withdrawal symptoms throughout the 72-hr abstinence period, had greater nicotine preference after abstinence, and lapsed back to smoking significantly sooner than CS. The relationship between group and smoking lapse latency was mediated by baseline depression and nicotine withdrawal symptom severity but not by effects of abstinence on craving or nicotine reinforcement. CONCLUSIONS: Overall, these results indicate that negative affect is a key contributor to poor smoking cessation outcomes among those with schizophrenia.
INTRODUCTION:Schizophrenia is associated with a high prevalence of cigarette smoking. The aims of this study were to compare smokers with schizophrenia (SS) and control smokers without psychiatric illness (CS) on (a) cigarette craving and nicotine withdrawal symptom severity during a 72-hr smoking abstinence period; (b) nicotine reinforcement, before and after abstinence; and (c) latency to smoking lapse following abstinence. We also explored mediators of smoking lapse in SS and CS. METHODS: SS (n = 28) and CS (n = 27) underwent a nicotine versus denicotinized cigarette puff choice task before and after a 72-hr period of smoking abstinence that was experimentally controlled by providing cash reinforcement contingent on biochemical verification of abstinence. Twenty-four hours after the second choice task, participants could receive a low-value reinforcer if they had continued to abstain since the previous day. Those who remained abstinent were recontacted a week later to determine time of their smoking lapse. RESULTS: SS reported more severe cigarette craving and nicotine withdrawal symptoms throughout the 72-hr abstinence period, had greater nicotine preference after abstinence, and lapsed back to smoking significantly sooner than CS. The relationship between group and smoking lapse latency was mediated by baseline depression and nicotine withdrawal symptom severity but not by effects of abstinence on craving or nicotine reinforcement. CONCLUSIONS: Overall, these results indicate that negative affect is a key contributor to poor smoking cessation outcomes among those with schizophrenia.
Authors: Susan L Kenford; Stevens S Smith; David W Wetter; Douglas E Jorenby; Michael C Fiore; Timothy B Baker Journal: J Consult Clin Psychol Date: 2002-02
Authors: Gary K Burger; Robert D Yonker; Robert J Calsyn; Gary A Morse; W D Klinkenberg Journal: Int J Methods Psychiatr Res Date: 2003 Impact factor: 4.035
Authors: Marc L Steinberg; Jill M Williams; Kunal K Gandhi; Jonathan Foulds; Elizabeth E Epstein; Thomas H Brandon Journal: Psychol Addict Behav Date: 2012-05-28
Authors: Tony P George; Jennifer C Vessicchio; Angelo Termine; Deanna M Sahady; Cory A Head; W Thomas Pepper; Thomas R Kosten; Bruce E Wexler Journal: Neuropsychopharmacology Date: 2002-01 Impact factor: 7.853
Authors: Sarah H Heil; Jennifer W Tidey; Heather W Holmes; Gary J Badger; Stephen T Higgins Journal: Nicotine Tob Res Date: 2003-04 Impact factor: 4.244
Authors: Jillian J Weeks; Laura E Rupprecht; Anthony A Grace; Eric C Donny; Alan F Sved Journal: Nicotine Tob Res Date: 2020-02-06 Impact factor: 4.244
Authors: Joelle C Ferron; Timothy Devitt; Gregory J McHugo; Jessica A Jonikas; Judith A Cook; Mary F Brunette Journal: Community Ment Health J Date: 2016-03-01
Authors: Paige E Forrest; Amanda J Brinson; Jessica M Gannon; Tony P George; Kenneth A Perkins; Kadiamada Nanaiah Roy Chengappa Journal: J Clin Psychopharmacol Date: 2015-04 Impact factor: 3.153
Authors: Stephen T Higgins; Allison N Kurti; Marissa Palmer; Jennifer W Tidey; Antonio Cepeda-Benito; Maria R Cooper; Nicolle M Krebs; Lourdes Baezconde-Garbanati; Joy L Hart; Cassandra A Stanton Journal: Prev Med Date: 2019-05-02 Impact factor: 4.018
Authors: Eric C Donny; Dorothy K Hatsukami; Neal L Benowitz; Alan F Sved; Jennifer W Tidey; Rachel N Cassidy Journal: Prev Med Date: 2014-06-23 Impact factor: 4.018